Schedule 13G ownership disclosure
EVOKE PHARMA INC
Common Stock · CUSIP: 30049G302
Event date: 2025-11-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 31 · Class: 0.0%
- Morgan Stanley Smith Barney LLC
Shares: 31 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-25-000595
- Form type
- SCHEDULE 13G/A
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- Dec 05, 2025
- Reporting period
- Nov 30, 2025
- Description
- Schedule 13G beneficial ownership